Yaqi Zhou Selected Research

Yaqi Zhou Research Topics

Disease

6	Neoplasms (Cancer) 06/2022 - 01/2021
5	Hypoxia (Hypoxemia) 03/2022 - 01/2017
5	Inflammation (Inflammations) 03/2022 - 10/2017
4	Insulin Resistance 01/2022 - 01/2019
3	Body Weight (Weight, Body) 01/2022 - 01/2020
2	Pathologic Neovascularization 11/2022 - 01/2017
2	Carcinoma (Carcinomatosis) 06/2022 - 02/2013
2	Nasopharyngeal Carcinoma 02/2022 - 01/2022
2	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 02/2013
2	Atherosclerosis 12/2018 - 10/2017
1	Choroidal Neovascularization 11/2022
1	Triple Negative Breast Neoplasms 06/2022
1	Cancer Pain 06/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2022
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 02/2022
1	Azoospermia 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Obesity 11/2021
1	Cardiac Edema 01/2021
1	Neointima 01/2021
1	Endotoxemia 01/2021
1	Vascular System Injuries 01/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020
1	Stroke (Strokes) 01/2019
1	Brain Injuries (Brain Injury) 01/2019
1	Atherosclerotic Plaque (Atheroma) 12/2018
1	Marfan Syndrome (Marfan's Syndrome) 07/2018
1	Wounds and Injuries (Trauma) 01/2017
1	Thyroid Dysgenesis (Thyroid Agenesis) 02/2014
1	Papillary Carcinoma 02/2014
1	Papillary Thyroid Cancer 02/2013

Drug/Important Bio-Agent (IBA)

5	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 01/2017
4	Phosphotransferases (Kinase)IBA 11/2022 - 01/2019
4	Adenosine KinaseIBA 01/2021 - 10/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	LipidsIBA 01/2022 - 01/2020
2	FructoseIBA 01/2021 - 01/2019
2	Semaxinib (SU5416)IBA 01/2021 - 01/2019
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2021 - 01/2017
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2019 - 01/2017
2	Retinaldehyde (Retinal)IBA 01/2017 - 01/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2022
1	dezocine FDA Link 06/2022
1	azomycinIBA 03/2022
1	Fluorescent Dyes (Fluorescent Probes)IBA 03/2022
1	Liposomes (Liposome)IBA 03/2022
1	NitroreductasesIBA 03/2022
1	Cyclic PeptidesIBA 03/2022
1	Biomarkers (Surrogate Marker)IBA 02/2022
1	MicroRNAs (MicroRNA)IBA 02/2022
1	cordycepinIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	bisphenol AIBA 01/2022
1	Monomeric GTP-Binding ProteinsIBA 01/2022
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2021
1	VemurafenibIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Platelet-Derived Growth FactorIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2021
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Caspase 1 (ICE Protease)IBA 01/2019
1	istradefyllineIBA 01/2019
1	InflammasomesIBA 01/2019
1	Apolipoproteins E (ApoE)IBA 12/2018
1	ApolipoproteinsIBA 12/2018
1	CholesterolIBA 12/2018
1	oxidized low density lipoproteinIBA 12/2018
1	FibrillinsIBA 07/2018
1	S-AdenosylhomocysteineIBA 10/2017
1	AdenosylhomocysteinaseIBA 10/2017
1	Oxygen (Dioxygen)IBA 01/2017
1	EnzymesIBA 01/2017
1	Thyroxine (Levothyroxine)FDA LinkGeneric 02/2014
1	Messenger RNA (mRNA)IBA 02/2013

Therapy/Procedure

2	Therapeutics 11/2021 - 01/2021
1	Lasers (Laser) 11/2022